Fort Belvoir, VA1 Active Studies

Multiple Sclerosis Clinical Trials in Fort Belvoir, VA

Find 1 actively recruiting multiple sclerosis clinical trials in Fort Belvoir, VA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
198
Enrolling

Recruiting Multiple Sclerosis Studies in Fort Belvoir

About Multiple Sclerosis Clinical Trials in Fort Belvoir

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 1 multiple sclerosis clinical trials recruiting participants in Fort Belvoir, VA. These studies are seeking a combined 198 participants. Research is being sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in Fort Belvoir — FAQ

Are there multiple sclerosis clinical trials in Fort Belvoir?

Yes, there are 1 multiple sclerosis clinical trials currently recruiting in Fort Belvoir, VA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fort Belvoir?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fort Belvoir research site will contact you about next steps.

Are clinical trials in Fort Belvoir free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fort Belvoir studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 1 active trials in Fort Belvoir are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated July 13, 2026 from ClinicalTrials.gov